Search | Page 37 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 10:43am.

  2. A Phase II Study of 5-Azacitidine and Sargramostim as Maintenance Treatment After Definitive Therapy for Poor-risk AML or MDS

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 10:38am.

  3. Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 10:36am.

  4. SCT Plus Immune Therapy in Average Risk AML/MDS

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 9:52am.

  5. Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... This is a Phase 2, open-label, randomized, controlled clinical study of pediatric subjects treated with pamidronate with calcium and ...

    Clinical Trial last updated 04/27/2016 - 3:48pm.

  6. Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... to assess the safety, tolerability, and preliminary clinical effects of BVD-523 given orally, twice daily for 21-day cycles, in ...

    Clinical Trial last updated 04/27/2016 - 3:39pm.

  7. T-cell Depleted Alternative Donor Transplantation

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... ejection fraction < 45%; can be lower if patient is not in clinical cardiac failure and a reduced intensity conditioning regimen is used. ...

    Clinical Trial last updated 04/29/2016 - 3:38pm.

  8. Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral CDAi in Patients With MDS

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... stage the selected dose will be confirmed and evaluated for clinical activity, including response rate. ...

    Clinical Trial last updated 04/27/2016 - 2:05pm.

  9. A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... Phase 1 dose escalation (Part A) and expansion (Part B), clinical study of CC-90002, administered by intravenous (IV) infusion, in ...

    Clinical Trial last updated 04/27/2016 - 1:31pm.

  10. A Combination Study of PF-04449913 and Azacitidine In 1st Line MDS, AML and CMML Patients

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... dysplasia, and Chronic Myelomonocytic Leukemia (CMML). This clinical study includes two components: (a) a Phase 1b safety lead in and (b) a ...

    Clinical Trial last updated 04/27/2016 - 1:20pm.